Literature DB >> 27988988

Prediction of nonalcoholic fatty liver in prospective liver donors.

Narendra S Choudhary1, Neeraj Saraf1, Sanjiv Saigal1, Ajay Duseja2, Dheeraj Gautam3, Lipika Lipi3, Amit Rastogi1, Sanjay Goja1, Prashant Bhangui1, Sumana K Ramchandra1, Yalakanti Raghavendra Babu1, Arvinder S Soin1.   

Abstract

BACKGROUND: Metabolic risk factors should be important in addition to imaging for prediction of steatosis in prospective liver donors.
MATERIALS AND METHODS: The study group included all prospective liver donors who had a liver biopsy during workup. Risk factors of metabolic syndrome were analyzed, and body mass index (BMI) ≥25 kg/m2 was used in place of waist circumference. Three BMI cutoffs (25, 28, and 30 kg/m2 ) and two CT-measured liver attenuation index (LAI) cutoffs (<5 and ≤10) were used for steatosis assessment of ≥5%, ≥10%, and ≥20%.
RESULTS: Of the 573 prospective donors (307 females), 282 (49.2%) donors had nonalcoholic fatty liver (NAFL). When donors with NAFL were compared with donors having normal histology, multivariate analysis showed BMI, ALT, triglycerides, and LAI as significant predictors of NAFL. BMI ≥25 kg/m2 and LAI <10 were better cutoffs. The presence of ≥2 metabolic risk factors had better sensitivity than CT-LAI for the presence of NAFL and ≥20% steatosis (58% and 54% vs 47% and 22%, respectively, for CT-LAI ≤10). The presence of LAI >10 and <2 metabolic risk factors predicted <10% steatosis with 96% specificity and 92% positive predictive value.
CONCLUSION: The presence of ≥2 metabolic risk factors improves sensitivity of CT-LAI for prediction of donor steatosis.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  donor; histology; liver transplantation; metabolic syndrome; steatosis

Mesh:

Year:  2017        PMID: 27988988     DOI: 10.1111/ctr.12890

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

Review 1.  Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.

Authors:  Arka De; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-09-20

2.  Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Srikanth Thummala; Neeraj Saraf; Amit Rastogi; Prashant Bhangui; Thiagrajan Srinivasan; Sanjay K Yadav; Samiran Nundy; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2020-02-14

3.  Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors.

Authors:  Narendra S Choudhary; Neeraj Saraf; Sanjiv Saigal; Ajay Duseja; Dheeraj Gautam; Amit Rastogi; Prashant Bhangui; Srinivasan Thiagrajan; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2021-02-02

4.  Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.

Authors:  Anshuman Elhence; Bhavik Bansal; Hardik Gupta; Abhinav Anand; Thakur P Singh; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.